Tabla de Contenidos: “…Gut as an endocrine organ : the role of nutrient-sensing in energy metabolism / Minghan Wang -- Central glucose sensing and control of food intake and energy homeostasis / Lourdes Mounien and Bernard Thorens -- Abnormalities in insulin secretion in type 2 diabetes mellitus / Taly Meas and Pierre-Jean Guillausseau -- Adipokine production by adipose tissue : a novel target for treating metabolic syndrome and its sequelae / Vanessa DeClercq ... [et al.] -- Hepatic metabolic dysfunctions in type 2 diabetes : insulin resistance and impaired glucose production and lipid synthesis / Ruojing Yang -- Energy metabolism in skeletal muscle and its link to insulin resistance / Minghan Wang -- Mechanisms and complications of metabolic syndrome / Minghan Wang -- Emerging therapeutic approaches for dyslipidemia associated with high LDL and low HDL / Margrit Schwarz and Jae B. …”
Enlace del recurso

Tabla de Contenidos: “….] -- Liver malignancies / Kristy K Brock and Laura A. Dawson -- Non-hepatic gastrointestinal malignancies / Daniel T. …”
Enlace del recurso

Tabla de Contenidos: “….) -- Página legal -- Unidad 1 -- Cap. 01-Sarampión -- Cap. 02-Rubeola -- Cap. 03-Parotiditis -- Cap. 04-Exantema -- Cap. 05-Varicela -- Cap. 06- Mononucleosis -- Cap. 07-Hepatitis virales -- Cap. 08-Rabia -- Cap. 09-Poliomielitis -- Cap. 10-Dengue -- Cap. 11-Influenza -- Cap. 12- Citomegalovirus -- Cap. 13-Infección VIH -- Unidad 2 -- Cap. 14-Estreptococias -- Cap. 15-Streptococcus -- Cap. 16-Haemophilus -- Cap. 17- Staphylococcus aureus -- Cap. 18-Tosferina -- Cap. 19-Tetanos -- Unidad 3 -- Cap. 20-Enfermedades salmonellas -- Cap. 21-Tuberculosis -- Cap. 22-Infecciones micoplasmas -- Cap. 23-Parasitosis intestinales -- Cap. 24-Malaria -- Cap. 25-Toxoplasmosis -- Cap. 26-Fiebre -- Cap. 27-Fiebre sin causa -- Cap. 28-Adenitis cervical -- Unidad 4 -- Cap. 29-Desarrollo del sistema respiratorio -- Cap. 30-Imaginologia del torax -- Cap. 31- Oxigenoterapia -- Cap. 32-Infección respiratoria aguda -- Cap. 33- Larigotraqueitis -- Cap. 34-Bronquiolitis -- Cap. 35-Neumonias bacterianas y virales -- Cap. 36-Derrames pleurales y empiemas -- Cap. 37-Neumonia afebril del lactante -- Cap. 38-El nino con neumonia recurrente -- Cap. 39-Epidemiología y diagnóstico del asma bronquial -- Cap. 40-Tratamiento ambulatorio del asma -- Cap. 41-Crisis asmática en niños -- Cap. 42- Aerosolterapia -- Cap. 43-Sindrome rinosinobronquial -- Cap. 44-Tos cronica -- Cap. 45-Estridor cronico -- Cap. 46-Neumonías aspirativas -- Cap. 47-Fibrosis Quística -- Cap. 48-Displasia broncopulmonar -- Cap. 49-Cuerpo extraño en la vía aérea -- Cap. 50-Insuficiencia respiratoria -- Cap. 51-Enfermedad pulmonar intersticial difusa en niños -- Puntos de Venta…”

Tabla de Contenidos: “…Hinrichs -- Pathogenesis and eitiology of periodontal disease : plaque, inflammation and inflammatory cascade, mechanism of bone loss -- Bacteriology of periodontal disease / Colin Harvey -- Gingivitis : clinical features, diagnosis, treatment options -- Periodontitis : clinical features, progression, diagnosis, treatment options -- Local and regional consequences of periodontal disease : oronasal fistulas, osteomyelitis, oral cancer, pathologic fractures, class ii perio-endo lesions, ocular problems, blindness -- Systemic manifestations of periodontal disease : hepatic, renal, cardiac, pulmonary, osteoporosis, cerebral infarction, diabetes mellitus, adverse pregnancy effects, chronic systemic disease, early mortality -- Unusual forms of periodontal disease : eruptive gingivitis, caudal stomatitis, juvenile hyperplastic periodontitis -- Dental radiology for periodontal disease / Jerzy Gawor -- The complete dental cleaning : supra and subgingival scaling, polishing, sulcal lavage, oral evaluation and probing -- Advanced non-surgical therapy : root planing and subgingival curettage -- Local antibiotic usage : perioceutic administration (doxirobe) -- Home plaque control : active (brushing and rinses) and passive (chews and treats) options -- Antibiotics in periodontal disease / R. …”

“…Productions include 'Chopped Liver' (2006-2009), 'Body Armour' (2011-2013) and 'Viral' (2018-2019)—all dealing with Hepatitis C; 'North West of Nowhere' (2014-2016), which deals with sexual health and healthy relationships; and 'Scar Trees' (2019), which addresses family violence. …”

Tabla de Contenidos: “….] -- Molecular mechanisms of hepatitis C virus-induced cellular transformation / Donna Sir and Jing-hsiung James Ou -- Clinical aspects of HTLV-1 associated cancer / Masao Matsuoka -- Oncogenic potential of the HTLV-1 tax protein / Susan J. …”
Enlace del recurso

Tabla de Contenidos: “…Infecciones de transmisión sexual; Página legal; Contenido; Prólogo; Sección I Aspectos globales de las infecciones de transmisión sexual; 1 Antecedentes históricos de las infecciones de transmisión sexual; 2 Epidemiología de las infecciones de transmisión sexual; 3 Aspectos médico-legales de las infecciones de transmisión sexual; Sección II Virus de transmisión sexual; 4 VIH como infección de transmisión sexual; 5 Virus del papiloma humano; 6 Infección por virus del herpes simple; 7 Molusco contagioso; 8 Hepatitis viral de transmisión sexual; 9 Citomegalovirus…”

Tabla de Contenidos: “…Gastrointestinal disorders -- Liver cirrhosis and complications -- Inflammatory bowel disease -- Nausea and vomiting -- Upper gastrointestinal disorders -- Viral hepatitis Part VI. Respiratory disorders -- Chronic obstructive pulmonary disease -- Asthma -- Cystic fibrosis -- Part VII. …”

Tabla de Contenidos: “…Portal Hypertension and Cirrhosis -- 10. Viral Hepatitis -- 11. Acute Pancreatitis -- 12. Stress Ulcer Prophylaxis -- 13. …”

Tabla de Contenidos: “…Part I: Introduction to Biopharmaceutics and Pharmacokinetics -- Chapter 1: Introduction to Biopharmaceutics and Pharmacokinetics -- Chapter 2: Mathematical Fundamentals in Pharmacokinetics -- Chapter 3: Biostatistics -- Part II: Fundamentals of Biopharmaceutics -- Chapter 4: Physiologic Factors Related to Drug Absorption -- Chapter 5: Drug Distribution and Protein Binding -- Chapter 6: Physiology of Drug Elimination -- Chapter 7: Biopharmaceutic Considerations in Drug Product Design and In Vitro Drug Product Performance -- Chapter 8: Drug Product Performance, In Vivo: Bioavailability and Bioequivalence -- Chapter 9: Modified-Release Drug Products and Drug Devices -- Chapter 10: Targeted Drug Delivery Systems and Biotechnology Products -- Part III: Pharmacokinetic Principles -- Chapter 11: Introduction to Pharmacokinetic and Pharmacodynamic Models and Analyses -- Chapter 12: One-Compartment Open Model: Intravenous Bolus Administration -- Chapter 13: Multicompartment Models: Intravenous Bolus Administration -- Chapter 14: Intravenous Infusion -- Chapter 15: Pharmacokinetic Calculations for Drug Elimination and Clearance -- Chapter 16: Pharmacokinetics of Drug Absorption -- Chapter 17: Multiple-Dosage Regimens -- Chapter 18: Nonlinear Pharmacokinetics -- Chapter 19: Empirical Models, Mechanistic Models, Statistical Moments, and Noncompartmental PK/PD Analyses -- Chapter 20: Applications of Software Packages in Pharmacokinetics -- Part IV: Pharmacodynamics and Clinical Pharmacokinetics -- Chapter 21: Pharmacogenetics, Drug Metabolism, Transporters, and Individualization of Drug Therapy -- Chapter 22: Relationship between Pharmacokinetics and Pharmacodynamics -- Chapter 23: Application of Pharmacokinetics to Clinical Situations -- Chapter 24: Application of Pharmacokinetics and Pharmacodynamics to Aging, Obese, and Pediatric Patients -- Chapter 25: Dose Adjustment in Renal and Hepatic Diseases -- Part V: Biopharmaceutics and Pharmacokinetics in Drug Product Development -- Chapter 26: Biopharmaceutical Aspects of the Active Pharmaceutical Ingredient and Pharmaceutical Equivalence -- Chapter 27: Rational Drug Product Development, Quality, and Performance -- Chapter 28: FDA-Approved Novel Dosage Forms -- Chapter 29: Clinical Development and Therapeutic Equivalence of Generic Drugs and Biosimilar Products -- Chapter 30: Pharmacokinetics and Pharmacodynamics in Clinical Drug Product Development -- Glossary…”

Tabla de Contenidos: “…Byars and Laura Marsh -- Managing depression in traumatic brain injury / Oludamilola Salami and Vani Rao -- Managing psychiatric aspects of seizure disorders Alex Thompson -- Distress and depression in cancer care / Janeta Tansey and Donna Greenberg -- Depression in the patient with hepatitis / C Joseph A. Locala -- Psychiatric aspects of AIDS / Mary Ann Cohen -- Managing depression and renal failure / Thomas W. …”

“…Está bien demostrado que la cirrosis, hepatitis virales y la diabetes mellitus representan un sistema muy articulado que altera la fisiología, el metabolismo y la citoarquitectura del hígado. …”
Acceso restringido con credenciales UPSA

“…Está bien demostrado que la cirrosis, hepatitis virales y la diabetes mellitus representan un sistema muy articulado que altera la fisiología, el metabolismo y la citoarquitectura del hígado. …”
Enlace del recurso

Tabla de Contenidos: “…Contraceptive Use and Controlled Fertility -- Copyright -- Contents -- Preface -- The Relationship Between Fertility and Maternal Mortality -- DEFINITIONS AND MEASUREMENT ISSUES -- Measures -- Sources of Data -- Problems of Measurement -- WORLD PATTERNS -- ASPECTS OF FERTILITY AS RISK FACTORS FOR MATERNAL MORALITY -- Parity/Gravidity -- Interaction Between Age and Gravidity/Parity -- Hospital Studies: Primigravid/Primiparous Women -- Hospital Studies: Multigravid/Multiparous Women -- Short Birth Intervals -- OTHER IMPORTANT RISK FACTORS -- Lack of Antenatal Care -- Distance -- Socioeconomic Status -- Traditional Behavior -- Birth Practices -- Female Circumcision -- CAUSAL PATTERNS OF MORTALITY -- Differences by Area -- ASPECTS OF FERTILITY AND THE MAJOR CAUSES OF DEATH -- Abortion -- Difficult Labor -- Hemorrhage/Anemia -- Hypertensive Disease of Pregnancy -- Infectious Disease -- Hepatitis -- Tuberculosis -- Malaria -- CONCLUSION -- APPENDIX-CONTENTS OF CAUSAL CATEGORIES -- REFERENCES -- Health Effects of Contraception -- INTRODUCTION -- ORAL CONTRACEPTIVES -- Noncontraceptive Benefits -- Adverse Health Effects -- Cardiovascular Effects -- Metabolic Effects -- Neoplastic Diseases -- Other Effects -- INTRAUTERINE DEVICES -- Adverse Health Effects -- BARRIER METHODS -- Condoms -- Spermicides and the Contraceptive Sponge -- Diaphragm with Spermicide -- Cervical Caps -- LONG-ACTING METHODS -- Injectables -- Implants -- TUBAL STERILIZATION -- Sterilization Reversal -- VASECTOMY -- Mortality -- Morbidity -- Long-Term Safety -- Vasectomy Reversal -- REFERENCES -- Mechanisms for the Association of Maternal Age, Parity, and Birth Spacing with Infant Health -- INTRODUCTION -- Overview -- Causes of Infant Deaths -- Low Birthweight and Prematurity -- YOUNG MATERNAL AGE AND PRIMIPARITY -- Effects on Birthweight and Prematurity…”

Tabla de Contenidos: “…14 Herpesvirus Adriana Hernández Alarcón, Leticia Colín Malváez, César Armando Sifuentes Cantú15 Influenza Carlos Lenin Pliego Reyes; 16 Conceptos actuales de la infección por virus de hepatitis C Andrés Lupián Sánchez, Fernando Rogelio Espinosa López, Laura Luz Arana Luna, Adriana Rodríguez Galván; 17 Teniasis y cisticercosis José Humberto Arcos Correa, Marcela Vela Amieva, Mónica Chapa Ibargüengoitia; 18 Paludismo Maricela Escarela Serrano, Elizabeth Novoa Becerril; 19 Enfermedad de chagas Jorge Escobedo de la Peña…”

Tabla de Contenidos: “…Introduction and History of the Chemistry of Nucleic Acids Therapeutics -- Antisense RNA Therapeutics: A Brief Overview -- Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion -- Design and Delivery of SINEUP: A New Modular Tool to Increase Protein Translation -- How to Design U1 snRNA Molecules for Splicing Rescue -- Conjugation of Nucleic Acids and Drugs to Gold Nanoparticles -- Determination of Optimum Ratio of Cationic Polymers and Small Interfering RNA with Agarose Gel Retardation Assay -- Generation of Protein-Phosphorodiamidate Morpholino Oligomer Conjugates for Efficient Cellular Delivery via Anthrax Protective Antigen -- Development and Use of Cellular Systems to Assess and Correct Splicing Defects -- Modeling Splicing Variants Amenable to Antisense Therapy by Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells -- In Vitro Models for the Evaluation of Antisense Oligonucleotides in Skin -- In Vitro Delivery of PMOs in Myoblasts by Electroporation -- Rapid Determination of MBNL1 Protein Levels by Quantitative Dot Blot for Evaluation of Antisense Oligonucleotides in Myotonic Dystrophy Myoblasts -- Evaluation of Exon Skipping and Dystrophin Restoration in In Vitro Models of Duchenne Muscular Dystrophy -- Generation of Human iPSC-Derived Myotubes to Investigate RNA-Based Therapies In Vitro -- Eye on a Dish Models to Evaluate Splicing Modulation -- Establishment of In Vitro Brain Models for AON Delivery -- Considerations for Generating Humanized Mouse Models to Test Efficacy of Antisense Oligonucleotides -- Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies -- Use of Small Animal Models for Duchenne and Parameters to Assess Efficiency upon Antisense Treatment -- In Vivo Models for the Evaluation of Antisense Oligonucleotides in Skin -- Delivery of Antisense Oligonucleotides to the Mouse Retina -- Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections -- Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System -- Preclinical Safety Assessment of Therapeutic Oligonucleotides -- Preclinical Evaluation of the Renal Toxicity of Oligonucleotide Therapeutics in Mice -- Protocol for Isolation and Culture of Mouse Hepatocytes (HCs), Kupffer Cells (KCs), and Liver Sinusoidal Endothelial Cells (LSECs) in Analyses of Hepatic Drug Distribution -- Patent Considerations When Embarking on New Antisense Drug Programs…”

Tabla de Contenidos: “…""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY""…”

Tabla de Contenidos: “…IMMUNIZATION SAFETY REVIEW -- Copyright -- Acknowledgments -- Contents -- Executive Summary -- PLAUSIBILITY ASSESSMENT -- Biological Plausibility -- Causality -- SIGNIFICANCE ASSESSMENT -- PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Research -- Clinical Research -- Basic Science Research -- Communications -- SUMMARY -- REFERENCES -- Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders -- ORIGINS OF THE IMMUNIZATION SAFETY REVIEW PROJECT -- THE CHARGE TO THE COMMITTEE -- THE STUDY PROCESS -- THE FRAMEWORK FOR ASSESSING CAUSALITY -- UNDER REVIEW: THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS -- Thimerosal in Vaccines -- Neurodevelopmental Disorders -- Autism -- Attention Deficit/Hyperactivity Disorder (ADHD) -- Speech or Language Delay -- PLAUSIBILITY ASSESSMENT -- Evidence Regarding Association: Biological Plausibility -- Mercury Toxicokinetics -- Comparisons of Ethylmercury and Methylmercury -- Health Effects of High-Dose Exposures to Thimerosal, Ethylmercury, and Methylmercury -- Health Effects of Low-Dose Exposures to Thimerosal and Methylmercury -- Investigations Related to Mercury and Heavy Metals in Children with Autism -- Application of Methylmercury Exposure Guidelines to Thimerosal Exposure from Vaccines -- Biological Plausibility Argument -- Evidence Regarding Association: Case Reports, Case Series, and Uncontrolled and Controlled Epidemiological Studies -- Case Reports and Case Series -- Epidemiological Studies -- CAUSALITY ARGUMENT -- SIGNIFICANCE ASSESSMENT -- Concern Regarding Neurodevelopmental Disorders -- Continued Exposure to Thimerosal -- Use of Thimerosal-Containing Vaccines in Other Countries -- Confusion from Changes in Hepatitis B Immunization Policy -- Trust in the Safety of Vaccines -- Conclusion…”

“…Problemas prevalentes en enfermedades infecciosas son la hepatitis y las de transmisión sexual. El SIDA presenta baja tasa: 15,1 por millón de habitantes. …”
Acceso con credenciales UPSA

Tabla de Contenidos: “…Pancreatitis 25. Viral HepatitisSECTION 4 Renal Disorders 26. Acute Kidney Injury 27. …”